Eliaz Therapeutics Inc. research brief

CIK 2042609 Copy CIK

Generated Nov. 7, 2026, 4:08 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: SANTA ROSA CA. Reported legal jurisdiction: DE. These do not establish investor residence or where funds were deployed.

• Oct. 24, 2025 · D · 0001062993-25-016285 · Source evidence

  Reported offering amount: 850000 USD. Reported amount sold: 850000 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Eliaz Therapeutics Inc. research brief,” CIK 2042609, retrieved Nov. 7, 2026, 4:08 a.m.. Cite the specific accessions used. No amounts have been summed.